A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence-based method to predict which patients are most likely to experience a recurrence and ...
Researchers have developed and validated a machine learning--based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence. Most deaths from ...